Blood Clot Drug Xarelto Receives FDA Nod for Use in Patients at High Risk for Stroke

by Kathy Jones on  November 5, 2011 at 6:30 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

The US Food and Drug Administration has extended the approved indications for Bayer Healthcare's blood clot drug, Xarelto. The latter will now be used for treating abnormal heart rhythm patients at high risk for stroke.
 Blood Clot Drug Xarelto Receives FDA Nod for Use in Patients at High Risk for Stroke
Blood Clot Drug Xarelto Receives FDA Nod for Use in Patients at High Risk for Stroke

Xarelto was first approved by the FDA for treating blood clots, deep vein thrombosis, and pulmonary embolism following knee or hip replacement surgery.

The drug, being developed by Bayer in collaboration with Johnson & Johnson, will now be used in preventing blood clots among patients with atrial fibrillation.

FDA's director of cardiovascular and renal products division, Dr Norman Stockbridge said that doctors now have another option for treating patients who have high risk of developing blood clots. "This approval gives doctors and patients another treatment option for a condition that must be managed carefully", he said.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Thalassemia Diet Lifestyle and Heart Disease Mitral Valve Stenosis And Mitral Valve Replacement Congenital Heart Disease Signature Drug Toxicity Stress and the Gender Divide Stroke Facts Stroke Hyperventilation 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive